Pathophysiology of peripheral arterial disease and risk factors for its development

John R. Bartholomew, MD
Section Head, Vascular Medicine, Department of Cardiovascular Medicine, Cleveland Clinic
Cleveland, OH

Jeffrey W. Olin, DO
Professor of Medicine and Director of Vascular Medicine, Zena and Michael A. Wiener Cardiovascular Institute, Mt. Sinai School of Medicine, New York, NY

Correspondence: John R. Bartholomew, MD, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, S60, Cleveland, OH 44195; barthoj@ccf.org

Dr. Bartholomew reported that he has received honoraria from GlaxoSmithKline for teaching and speaking.

Dr. Olin reported that he has received consulting fees from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership for serving on a medical advisory panel and has received research support and consulting fees from Genzyme.

John R. Bartholomew, MD
Section Head, Vascular Medicine, Department of Cardiovascular Medicine, Cleveland Clinic
Cleveland, OH

Jeffrey W. Olin, DO
Professor of Medicine and Director of Vascular Medicine, Zena and Michael A. Wiener Cardiovascular Institute, Mt. Sinai School of Medicine, New York, NY

Correspondence: John R. Bartholomew, MD, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, S60, Cleveland, OH 44195; barthoj@ccf.org

Dr. Bartholomew reported that he has received honoraria from GlaxoSmithKline for teaching and speaking.

Dr. Olin reported that he has received consulting fees from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership for serving on a medical advisory panel and has received research support and consulting fees from Genzyme.

John R. Bartholomew, MD
Section Head, Vascular Medicine, Department of Cardiovascular Medicine, Cleveland Clinic
Cleveland, OH

Jeffrey W. Olin, DO
Professor of Medicine and Director of Vascular Medicine, Zena and Michael A. Wiener Cardiovascular Institute, Mt. Sinai School of Medicine, New York, NY

Correspondence: John R. Bartholomew, MD, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, S60, Cleveland, OH 44195; barthoj@ccf.org

Dr. Bartholomew reported that he has received honoraria from GlaxoSmithKline for teaching and speaking.

Dr. Olin reported that he has received consulting fees from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership for serving on a medical advisory panel and has received research support and consulting fees from Genzyme.